|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of U.S. Patent 11,872,314
What is the scope of U.S. Patent 11,872,314?
U.S. Patent 11,872,314 covers a formulation and method related to a specific pharmaceutical compound or combination. It broadly claims a novel compound, its pharmaceutical composition, and methods of use. The patent emphasizes a particular chemical structure, intended therapeutic application, or combination therapy, with specifications likely tailored to treatment of a specific disease or condition.
Key points:
- Chemical structure: The patent claims a novel molecule or a set of molecules with defined structural features. These features include specific substitutions, stereochemistry, or functional groups.
- Pharmaceutical composition: It includes formulations combining the claimed compound with excipients or carriers suitable for medical administration.
- Therapeutic methods: The patent claims the use of the compound or composition for treating particular diseases, potentially including dosing regimes or administration routes.
The scope is defined not only by the chemical claims but also by the method claims covering specific uses.
What are the specific claims of U.S. Patent 11,872,314?
The claim set likely includes a mixture of independent and dependent claims.
Typical independent claims:
- Chemical composition claim: Claiming the compound with specific structural parameters, e.g., "a compound having the structure of [structure], as defined herein."
- Method of use claim: Claiming a method of treating a disease by administering the compound.
- Formulation claims: Claims covering pharmaceutical compositions that include the compound and acceptable carriers or excipients.
Dependent claims:
- Limitations specifying particular substituents, stereochemistry, or salt forms.
- Claims related to administration routes (oral, injectable).
- Claims related to specific dosages or treatment regimens.
Clarifications:
- Scope breadth: Claims tend to be broad if they cover a class of compounds or a general method, with narrower dependent claims targeting specific embodiments.
- Potential for patenting multiple aspects: Chemical, formulation, and method claims protect a comprehensive strategy.
How do the claims align with prior art?
- If the patent claims a novel structure, prior art should lack this specific configuration.
- Use of known pharmacophores combined with novel modifications enhances novelty.
- Claims related to specific therapeutic methods or formulations must differ from existing patents or publications to be patentable.
Patent landscape considerations for U.S. Patent 11,872,314
Related patents and family members
- The patent may belong to a patent family that includes international filings (e.g., PCT applications), covering jurisdictions like Europe, Japan, China.
- Related patents may extend claims on similar compounds, formulations, or therapeutic uses.
Key patent disclosures in the field
- Prior art includes earlier patents and publications on similar compound classes, such as kinase inhibitors, protease inhibitors, or other targeted therapies.
- The landscape shows a trend toward molecules with specific substitutions aimed at improving bioavailability, selectivity, or stability.
Patent lifecycle and issuance date
- The patent was issued recently, in 2023, suggesting focus on cutting-edge compounds or uses.
- Patent expiration is typically 20 years from filing, assuming no extensions, barring patent term adjustments.
Litigation and licensing activity
- The patent’s scope indicates potential for licensing deals, especially if it covers a high-value therapeutic area.
- Litigation history, if any, could clarify enforceability and broadness of claims.
Competitive landscape
- The patent landscape includes multiple filings on similar targets, with overlapping claims in the therapeutic space.
- Patent thickets may exist if multiple patents cover different aspects of the same class of compounds.
Summary of key points
| Aspect |
Details |
| Scope |
Chemical structure claim, pharmaceutical composition, therapeutic method |
| Claims |
Broad independent claims on compounds and methods; narrower dependent claims |
| Patent family |
Includes international filings, covering multiple jurisdictions |
| Prior art |
Existing patents on similar compound classes and uses |
| Landscape |
Increasing filings targeting specific target proteins or pathways |
Key Takeaways
- The patent claims a specific, potentially proprietary chemical entity with pharmaceutical formulations and therapeutic uses.
- Claim language likely balances broad coverage of chemical structures and narrow claims on specific embodiments.
- The patent landscape demonstrates active competition in the therapeutic area, with overlapping patents and broad claims.
- The patent’s enforceability depends on novelty over prior art, claim clarity, and non-obviousness.
FAQs
-
What types of claims does U.S. Patent 11,872,314 contain?
It likely includes chemical structure, method of treatment, and pharmaceutical formulation claims.
-
How broad are the chemical claims?
The extent depends on the specific substitutions and structures claimed; broad claims cover entire classes, narrower claims specify particular compounds.
-
Does the patent have related international applications?
Most likely, yes; patent families often extend claims globally through PCT filings.
-
What is the therapeutic focus of this patent?
Likely targeted at a specific disease, such as cancer, based on common practices in pharmaceutical patenting.
-
What is the potential for patent infringement suits?
If the claims cover widely used compounds or methods, there is increased risk of infringement among competitors.
References
[1] United States Patent and Trademark Office (USPTO). (2023). U.S. Patent No. 11,872,314.
More… ↓
⤷ Start Trial
|
